Directorate Change

Eurovestech PLC
15 May 2002

                                                                   15th May 2002


                        Eurovestech PLC ('Eurovestech')

                    Jan Leschley joins D-Pharm as Chairman


Eurovestech is pleased to report that Jan Leschly, has joined the board of
directors of D-Pharm Ltd ('D-Pharm'), one of its investee companies, as
Chairman.  Mr Leschly was previously Chief Executive Officer of SmithKline
Beecham plc (SKB). Prior to SKB, Mr Leschly was President and Chief Operating
Officer of E.R. Squibb after starting his career in the pharmaceutical industry
with Novo Industri A/S (currently Novo Nordisk).

D-Pharm is a biopharmaceutical company pioneering the development of lipid based
therapeutics. D-Pharm is engaged in both drug targeting and drug discovery based
on the company's technological platforms and has already R&D collaborations with
Nycomed Amersham Imaging and Eli Lilly & Company and a worldwide development and
commercialisation agreement with Shire Pharmaceuticals Group plc.

Commenting on the appointment, Richard Bernstein, Chief Executive of Eurovestech
said: 'This appointment represents a further endorsement of D-Pharm. We are
delighted that D-Pharm will now be able to benefit from Jan Leschly's
outstanding track record and his deep knowledge of and contacts in the
biopharmaceutical industry.'


Enquiries:

Eurovestech plc

Richard Bernstein, Chief Executive                          00 44 207 491 0770



                      This information is provided by RNS
            The company news service from the London Stock Exchange